Nurse Practitioner in Hayden, AL Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Mrs. Angel Ingle, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 645 Nicole Trl, Hayden, AL 35079 Phone: 205-789-6657 |
News Archive
Brentuximab vedotin-chemotherapy combination clinical trial for Hodgkin lymphoma announced
Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) that is also in single-agent clinical trials, including a pivotal trial for relapsed and refractory Hodgkin lymphoma and a phase II trial for systemic anaplastic large cell lymphoma.
Findings expand treatment options for hormone-dependent breast cancer
According to the United States Centers for Disease Control and Prevention, breast cancer is the most common cancer in women. For patients whose breast cancers are hormone-dependent, current treatment focuses on using drugs that block estrogen (a type of hormone) from attaching to estrogen receptors on tumor cells to prevent the cells from growing and spreading.
Juniper Pharmaceuticals' third quarter product revenues increase 22% to $7.2 million
Juniper Pharmaceuticals, Inc., a women's health therapeutics company, today announced financial results for the three months ended September 30, 2015.
Decreased connectivity between network-specific brain regions linked to cognitive deficit in MS
An estimated 2.3 million individuals are living with multiple sclerosis (MS) worldwide. Approximately half of all individuals with MS experience changes in cognition such as impaired concentration, attention, memory, and judgment. The underlying brain basis for these deleterious effects has been largely elusive.
Prasugrel linked to high-bleeding-risk in patients with stable coronary artery disease
Prasugrel-based dual antiplatelet therapy is associated with increased major bleeding after stent implantation for high-risk patients with stable coronary artery disease, according to a secondary analysis of the BASKET-PROVE II trial presented at ESC Congress for the first time today.
› Verified 6 days ago